AMOCELL

LIVE

Serial Number

79253893

Owner

Otsuka Pharmaceutical Factory, Inc.

Attorney

Jeffrey D. Larson

Filing Date

Dec 11, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

AMOCELL Trademark

Serial Number: 79253893 • Registration: 5969770

AMOCELL is a trademark filed by Otsuka Pharmaceutical Factory, Inc. on December 11, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Otsuka Pharmaceutical Factory, Inc. (3 trademarks)

115 Kuguhara, Tateiwa,

Entity Type: 03

Legal Representation

Attorney of Record

Jeffrey D. Larson

37 trademarks filed View all →

Correspondence Address

Jeffrey D. Larson Holland & Hart

P.O. Box 8749, TM Docketing

Attn: Trademark Docketing

Denver, CO 80201

UNITED STATES

Trademark Details

Filing Date

December 11, 2018

Registration Date

January 28, 2020

Published for Opposition

November 12, 2019

Goods & Services

Solutions for cell preservation for medical and veterinary purposes; preparations for medical and veterinary purposes namely, solutions for cell preservation for research relating to medical and veterinary treatment; reagents for medical purposes; medical diagnostic reagents; veterinary diagnostic reagents; biochemical preparations for medical or veterinary purposes

Chemicals for use in the biochemical and chemical industry; solutions for cell preservation other than for medical, veterinary or medical research purposes; biochemical preparations for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED

Mar 5, 2026 NREP

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jan 28, 2025 REM3

FINAL DECISION TRANSACTION PROCESSED BY IB

May 29, 2020 FINO

FINAL DISPOSITION NOTICE SENT TO IB

May 9, 2020 FICS

FINAL DISPOSITION PROCESSED

May 9, 2020 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 28, 2020 FICR

REGISTERED-PRINCIPAL REGISTER

Jan 28, 2020 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 12, 2019 NPUB

PUBLISHED FOR OPPOSITION

Nov 12, 2019 PUBO

NOTIFICATION PROCESSED BY IB

Nov 8, 2019 GPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Oct 23, 2019 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Oct 23, 2019 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 23, 2019 NONP

ASSIGNED TO LIE

Oct 9, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 3, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 13, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 13, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 13, 2019 TROA

REFUSAL PROCESSED BY IB

Apr 26, 2019 RFNP

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Apr 4, 2019 RFCS

REFUSAL PROCESSED BY MPU

Apr 4, 2019 RFRR

APPLICATION FILING RECEIPT MAILED

Mar 30, 2019 MAFR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 27, 2019 RFCR

NON-FINAL ACTION WRITTEN

Mar 26, 2019 CNRT

ASSIGNED TO EXAMINER

Mar 26, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 26, 2019 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Mar 11, 2019 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 7, 2019 REPR

Related Trademarks

More from this Owner

CELLSTOR

DIATRANZ

OTSUKA CLINICAL NUTRITION AMERICA

OTSUKA PHARMACEUTICAL FACTORY AMERICA

HINEX

More in Same Class

AMERICAN PLANT FOOD GROWTH STARTS HERE